Ontology highlight
ABSTRACT: Clinical relevance
This paper provides eye care practitioners with important information about the potential side effects of 0.01% atropine.Background
Eye care practitioners routinely administer 0.01% atropine eye drops nightly to slow the progression of myopia, but nobody has assessed accommodative lag or facility, near phoria, intraocular pressure or comfort of drop administration.Methods
All 21- to 30-year-old adults with no history of accommodative issues or therapy were eligible. During the baseline visit, participants underwent testing related to potential side effects. Participants then administered one drop of 0.01% atropine nightly to both eyes, and all tests were repeated 1 week later.Results
The average ± standard deviation age of the 31 participa
SUBMITTER: Cyphers B
PROVIDER: S-EPMC9903161 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature